CP
Christopher P Kiritsy sold $49K of PVLA stock
Christopher P Kiritsy, Dir of Palvella Therapeutics, Inc. (PVLA), sold 313 shares of PVLA stock worth $49K, per an SEC Form 4 filed Sep 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 2, 2026, 2 days before it was made public.
PVLA has moved -0.3% since the trade date, from $152.95 to $152.48 (Nov 13, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 4, 2026
- Filing delay
- 2 days
- Price since
- -0.3%
- Role
- Dir
- Source
- SEC Form 4